Neoadjuvant chemotherapy affects staging of colorectal liver metastasis - A comparison of PET, CT and intraoperative ultrasound

International Journal of Colorectal Disease

Volumn 26, Issue 2, 2011, Pages 165-171

  Spatz, Johann ^a   Holl, G ^a   Sciuk, J ^a   Anthuber, M ^a   Arnholdt, H M ^a   Markl B ^a  

^a KLINIKUM AUGSBURG   (Germany)

Author keywords

Colorectal liver metastasis; Intraoperative ultrasound; Neoadjuvant chemotherapy; PET; Staging accuracy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMIHEPATECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER RESECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79951724328     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1065-8     Document Type: Article

References (33)

1. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ (2007) Global cancer facts & figures 2007. American Cancer Society, Atlanta
2. Kune GA, Kune S, Field B, White R, Brough W, Schellenberger R, Watson LF (1990) Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne colorectal cancer study. Dis Colon Rectum 33(11):938-946
3. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ (1997) Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 84(12):1731-1736
4. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343(8910):1405-1410 (Pubitemid 24167517)
5. Khatri VP, Petrelli NJ, Belghiti J (2005) Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23(33):8490-8499
6. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O et al (2004) Rescue surgery for unresectable colorectal liver metastases down-staged by chemotherapy: a model to predict long-term survival. Ann Surg 240(4):644-657, discussion 657-648
7. Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S, Brunetti IM, Ferraldeschi R, Naso G, Filipponi F et al (2009) Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg 249(3):420-425
8. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25(29):4575-4580 (Pubitemid 350035315)
9. Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ et al (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23 (36):9243-9249
10. Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M (2006) Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 93(8):1001-1006 (Pubitemid 44214852)
11. Grundmann RT, Hermanek P,Merkel S, Germer CT, Grundmann RT, Hauss J, Henne-Bruns D, Herfarth K, Hermanek P, Hopt UT et al (2008) Diagnosis and treatment of colorectal liver metastases - workflow. Zentralbl Chir 133(3):267-284
12. Masi G, Cupini S, Marcucci L, Cerri E, Loupakis F, Allegrini G, Brunetti IM, Pfanner E, Viti M, Goletti O et al (2006) Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 13(1):58-65 (Pubitemid 43117646)
13. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007-1016 (Pubitemid 351392040)
14. Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R, Riemann J, Rodel C, Sauer R, Wieser M et al (2008) Update S3-guideline "colorectal cancer" 2008. Z Gastroenterol 46(8):799-840
15. Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, Sobrero A, Ychou M (2009) Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 20(6):985-992
16. Garcea G, Ong SL, Maddern GJ (2009) The current role of PET-CT in the characterization of hepatobiliary malignancies. HPB (Oxford) 11(1):4-17
17. Kong G, Jackson C, Koh DM, Lewington V, Sharma B, Brown G, Cunningham D, Cook GJ (2008) The use of 18F-FDG PET/CT in colorectal liver metastases - comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 35(7):1323-1329
18. Ruers TJ, Wiering B, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, Pruim J, Dekker HM, Krabbe PF, Oyen WJ (2009) Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med 50(7):1036-1041
19. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240(6):1027-1034, discussion 1035-1026
20. Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH (2005) Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16(8):1311-1319 (Pubitemid 41158476)
21. Siperstein AE, Berber E, Ballem N, Parikh RT (2007) Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 246(4):559-565 (Pubitemid 47480598)
22. Coenegrachts K, De Geeter F, ter Beek L, Walgraeve N, Bipat S, Stoker J, Rigauts H (2009) Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol 19(2):370-379
23. Konopke R, Bunk A, Kersting S (2008) Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy. Ultraschall Med 29(Suppl 4):S203-S209
24. Wiering B, Vogel WV, Ruers TJ, Oyen WJ (2008) Controversies in the management of colorectal liver metastases: role of PET and PET/CT. Dig Surg 25(6):413-420
25. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237(1):123-131
26. Larsen L, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, Laurberg S (2009) Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastasis from colorectal cancer? Eur J Radiol 69(2):308-313
27. Rafaelsen SR, Jakobsen A, Danish Colorectal Cancer Group South UoSD (2010) Contrast enhanced ultrasonography versus multidetector-computed tomography in detection of liver metastases from colorectal cancer. A prospective, blinded, patient by patient analysis. Colorectal Dis. doi:10.1111/j.1463-1318.2010.02288.x
28. Castaing D, Emond J, Kunstlinger F, Bismuth H (1986) Utility of operative ultrasound in the surgical management of liver tumors. Ann Surg 204(5):600-605 (Pubitemid 17176782)
29. Sietses C, Meijerink MR, Meijer S, van den Tol MP (2010) The impact of intraoperative ultrasound on the surgical treatment of patients with colorectal liver metastasis. Surg Endosc 24(8):1917-1922
30. Wildi SM, Gubler C, Hany T, Petrowsky H, Clavien PA, JochumW, Gerlach T, Fried M, Mullhaupt B (2008) Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. J Clin Ultrasound 36(1):20-26 (Pubitemid 350309016)
31. Joyce DL, Wahl RL, Patel PV, Schulick RD, Gearhart SL, Choti MA (2006) Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases. Arch Surg 141(12):1220-1226, discussion 1227
32. Adam R, Wicherts DA, de Haas RJ, Aloia T, Levi F, Paule B, Guettier C, Kunstlinger F, Delvart V, Azoulay D et al (2008) Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26 (10):1635-1641
33. Rydzewski B, Dehdashti F, Gordon BA, Teefey SA, Strasberg AM, Siegel BA (2002) Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Am J Roentgenol 178(2):353-358 (Pubitemid 34098037)